NDC 75788-115

BREXAFEMME

Ibrexafungerp

BREXAFEMME is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Scynexis, Inc.. The primary component is Ibrexafungerp Citrate.

• Product ID: 75788-115_c3f51fe9-0886-a172-e053-2a95a90a48dc
• NDC: 75788-115
• Product Type: Human Prescription Drug
• Proprietary Name: BREXAFEMME
• Generic Name: Ibrexafungerp
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-01
• Marketing Category: NDA /
• Application Number: NDA214900
• Labeler Name: SCYNEXIS, INC.
• Substance Name: IBREXAFUNGERP CITRATE
• Active Ingredient Strength: 150 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 75788-115-04

1 BLISTER PACK in 1 CARTON (75788-115-04) > 4 TABLET, FILM COATED in 1 BLISTER PACK

• Marketing Start Date: 2021-07-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details